Literature DB >> 34344853

Indication of Surgical Hepatectomy for the Patients of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombosis.

Yusuke Nishizawa1, Kaori Kuramitsu1, Masahiro Kido1, Shohei Komatsu1, Hidetoshi Gon1, Takeshi Urade1, Shinichi So1, Jun Ishida1, Sachiyo Shirakawa1, Hironori Yamashita1, Daisuke Tsugawa1, Sachio Terai1, Sadaki Asari1, Hiroaki Yanagimoto1, Hirochika Toyama1, Tetsuo Ajiki1, Takumi Fukumoto1.   

Abstract

The prognosis of hepatocellular carcinoma (HCC) presenting with inferior vena cava tumor thrombus (IVCTT) is extremely poor. The aim of this study was to reveal the postoperative course and to identify patients who have survived surgical hepatectomy among HCC patients with IVCTT. Between January 2006 and December 2018, 643 patients underwent surgical hepatectomy for HCC at Kobe University Hospital. Among them, 20 patients were categorized as Vv3 according to the Japanese staging system. We retrospectively collected detailed data on these patients. The statistical, clinical, and pathological data were recorded prospectively and analyzed retrospectively. The median survival time was 9.8 months. Among all patients, 11 (55%) achieved R0 resection, and only two survivors were from this group. The number of tumors (solitary vs. multiple; p=0.050) and pathological Vp (pVp0 vs. other; p=0.009) were identified as risk factors for overall survival in the univariate analysis. In the multivariate analysis, pathological Vp (pVp0 vs. other; p=0.037) was identified as a significant prognostic factor for survival. Pathological Vp affected overall survival among IVCTT patients; the median survival time was 53.7 months with pVp0, 10.2 months with pVp1, and 8.8 months with pVp2-4 (p=0.035). For patients with IVCTT, surgical hepatectomy should be indicated only for those who do not have portal vein invasion and could achieve R0 resection.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Inferior vena cava tumor thrombus; Portal vein tumor thrombus

Mesh:

Year:  2021        PMID: 34344853      PMCID: PMC8622260     

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  20 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

3.  Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Authors:  Masatoshi Kudo; Richard S Finn; Shukui Qin; Kwang-Hyub Han; Kenji Ikeda; Fabio Piscaglia; Ari Baron; Joong-Won Park; Guohong Han; Jacek Jassem; Jean Frederic Blanc; Arndt Vogel; Dmitry Komov; T R Jeffry Evans; Carlos Lopez; Corina Dutcus; Matthew Guo; Kenichi Saito; Silvija Kraljevic; Toshiyuki Tamai; Min Ren; Ann-Lii Cheng
Journal:  Lancet       Date:  2018-03-24       Impact factor: 79.321

5.  Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis.

Authors:  Shohei Komatsu; Masahiro Kido; Sadaki Asari; Hirochika Toyama; Tetsuo Ajiki; Yusuke Demizu; Kazuki Terashima; Tomoaki Okimoto; Ryohei Sasaki; Takumi Fukumoto
Journal:  Surgery       Date:  2017-10-12       Impact factor: 3.982

6.  Recurrence of hepatocellular carcinoma after surgery.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; M Makuuchi
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

7.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

8.  Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases.

Authors:  Shuichi Fukuda; Koji Okuda; Mahiro Imamura; Ichiro Imamura; Naofumi Eriguchi; Shigeaki Aoyagi
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

10.  Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study.

Authors:  Yi Wang; Lei Yuan; Rui-liang Ge; Yanfu Sun; Gongtian Wei
Journal:  Ann Surg Oncol       Date:  2012-09-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.